info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Insulin Delivery Devices Companies

In the realm of diabetes care, Insulin Delivery Devices companies lead in the development of advanced delivery solutions. Committed to enhancing the ease and precision of insulin administration, they design and produce innovative devices that empower individuals with diabetes to manage their condition effectively, promoting better health outcomes.

Insulin Delivery Devices Key Companies

 


Latest Insulin Delivery Devices Companies Update:

Abbott Recently reported strong performance across all segments, indicating potential market recovery after challenging years (MedTech Dive).


Medtronic Acquired EOFlow in 2022, strengthening their insulin pump portfolio and advancing research in diabetes management. They also received FDA approval for the MiniMed 780G system with automated corrections in April 2023.


Novo Nordisk Launched the first smart insulin pens, NovoPen 6 and NovoPen Echo Plus, in the UK in 2023, marking their entry into the connected insulin pen market.


Insulet Corporation Received FDA approval for their Omnipod® 5 Automated Insulin Delivery System in January 2022, offering a tubeless option for children and adults with Type 1 diabetes.


Dexcom Plans to launch a new CGM this summer for people who don't take insulin, potentially expanding their reach beyond the diabetes market (MedTech Dive).


List of Insulin Delivery Devices Key companies in the market

  • Becton, Dickinson and Company

  • Novo Nordisk A/S

  • Medtronic PLC

  • Sanofi

  • Eli Lilly

  • Johnson and Johnson

  • Tandem Diabetes Care Inc.

  • Biocon Limited

  • Hoffmann-La Roche

  • Braun Melsungen AG


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.